Loading...
Research Project
HOME-, CLINIC- AND LAB-BASED QUANTITATIVE MEASURES TO CAPTURE AND TRACK THE PRECLINICAL STAGE OF MACHADO-JOSEPH DISEASE/SPINOCEREBELLAR ATAXIA TYPE 3
Funder
Authors
Publications
Article Title: Impact of Dysphagia on Quality of Life in Machado-Joseph Disease
Publication . Mota, Joana Paz; Rodrigues, Inês Tello; Rodrigues, Inês Tello; Ferreira, Ana Filipa; Melo, Ana Rosa Vieira; Pires, Paula; Lopes, Pedro; Vasconcelos, João; Raposo, Mafalda; Lima, Manuela
Dysphagia is a frequent symptom of spinocerebellar ataxia type 3 (SCA3)/Machado-Joseph disease (MJD), being associated with alterations in nutritional intake and hydration, as well as an increased risk of aspiration pneumonia. This study aims to evaluate the impact of self-perceived dysphagia and its relationship with quality of life in SCA3/MJD mutation carriers. 41 SCA3/MJD mutation carriers from the Azorean cohort were recruited. The Swallowing Quality-of-Life Questionnaire (SWAL-QOL), the Eating Assessment Tool (EAT-10), the Functional Oral Intake Scale (FOIS), the Volume-Viscosity Swallow Test (V-VST), the Scale for the Assessment and Rating of Ataxia (SARA), the Inventory of Non-Ataxia Signs (INAS), and the Activities of Daily Living (ADL) were applied. Dysphagia was confirmed in 40% SCA3/MJD patients, whose SWAL-QOL was significantly decreased when compared to participants without dysphagia (p = 0.001). As expected, SCA3/MJD carriers with worse SWAL-QOL showed a high risk of dysphagia (p < 0.01), a worse functional oral intake of food and liquids (p < 0.01) and more severe ataxia (p < 0.01). Additionally, high severity of dysphagia reported on the INAS scale, (p < 0.01) and high frequency of swallowing disorders, perceived by SCA3/MJD carriers (p < 0.01) were observed in SCA3/MJD carriers with worse SWAL-QOL. Our findings confirm that dysphagia negatively impacts the quality of life of SCA3/MJD carriers, highlighting the need for permanent support by specialized healthcare professionals during disease progression. Additionally, we recommend that SCA3/MJD carriers with a score of 1 or higher on both the INAS dysphagia item and the ADL swallowing item be referred for specialized healthcare support in swallowing disorders.
Organizational Units
Description
Keywords
DIGITAL BIOMARKERS, MOTOR DEFICITS, MUTATED ATXN3 MRNA LEVELS, LONGITUDINAL STUDY, PREVENTIVE CLINICAL TRIALS,
Contributors
Funders
Funding agency
Fundação para a Ciência e a Tecnologia, I.P.
Funding programme
CEEC IND 2018
Funding Award Number
CEECIND/03018/2018/CP1556/CT0009
